Alcon, Inc. (NYSE:ACL) has filed its Form 20-F annual report of foreign
private issuer with the U.S. Securities and Exchange Commission (SEC).
An electronic version of this annual filing is available for review in
the Investors
and Media section of the company’s web
site or in the SEC’s EDGAR database at www.sec.gov.
Investors may obtain a printed copy of Alcon’s audited financial
statements free of charge by contacting Alcon Investor Relations either
by phone, e-mail or in writing at the address below.
Alcon Investor Relations
6201 South Freeway, MC TA7-5
Fort
Worth, TX 76134
Phone: 1-800-400-8599
investor.relations@alconlabs.com
www.alcon.com
About Alcon
Alcon, Inc. is the world’s leading eye care company, with sales of
approximately $6.5 billion in 2009. Alcon, which has been dedicated to
the ophthalmic industry for 65 years, researches, develops, manufactures
and markets pharmaceuticals, surgical equipment and devices, contacts
lens solutions and other vision care products that treat diseases,
disorders and other conditions of the eye. Alcon operates in 75
countries and sells products in 180 markets. For more information on
Alcon, Inc., visit the Company’s web site at www.alcon.com.
